Nektar Therapeutics Capital Reinvestment Ratio
Nektar Therapeutics capital reinvestment ratio. Nektar Therapeutics (NKTR) has a Capital Reinvestment Ratio of 0.00x as of June 2018, meaning it reinvests 0% of its operating cash flow ($959.64 Million) in capital expenditures ($2.75 Million). Check Nektar Therapeutics cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Nektar Therapeutics (1997–2018)
Capital reinvestment ratio of Nektar Therapeutics from 1997 to 2018. This chart tracks Nektar Therapeutics's Capital Reinvestment Ratio across 4 annual periods. Also explore net asset growth rate of Nektar Therapeutics to track the company's year-over-year net asset growth rate.
Nektar Therapeutics Capital Reinvestment Ratio by Year (1997–2018)
Nektar Therapeutics capital reinvestment ratio by year from 1997 to 2018. For the full cash flow conversion analysis, see cash flow conversion of Nektar Therapeutics.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2018 | 0.02x | $718.21 Million | $14.24 Million | ▼ -96.2% |
| 2009 | 0.52x | $39.74 Million | $20.70 Million | ▲ +132.4% |
| 2007 | 0.22x | $146.30 Million | $32.80 Million | ▼ -93.5% |
| 1997 | 3.47x | $4.98 Million | $17.26 Million | — |